Cannabis Industry Investor Conference: Company Executives Present April 20th
Cannabis Company Executives share vision, answer questions live at NEW YORK, April 16, 2021 /CNW/ – Virtual Investor Conferences and KCSA Strategic Communications today announced the agenda for the upcoming KCSA Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens... Read more
Decibel Announces Stock Option Grants
Ryan Allway April 16th, 2021 News, Top News CALGARY, AB, April 16, 2021 /CNW/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer and retailer, announces that it has granted, effective after market close on April 15, 2021, an aggregate of 4,246,003 stock options (each, an... Read more
Tryp Therapeutics Completes Up-Listing onto OTCQB and DTC Eligibility
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Fiore Cannabis Announces Virtual AGM Details
Ryan Allway April 14th, 2021 News, Top News Kelowna, British Columbia–(Newsfile Corp. – April 14, 2021) – Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced details for its upcoming virtual Annual General Meeting (the “AGM”) to... Read more
Fiore Cannabis Announces Preliminary Revenue Performance for First Quarter 2021
Ryan Allway April 13th, 2021 News, Top News Kelowna, British Columbia–(Newsfile Corp. – April 13, 2021) – Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced preliminary revenue results for the first quarter ended March 31, 2021... Read more
Psychedelic Wellness-Focused Company Delic Holdings Provides First Quarter 2021 Shareholder Update
Ryan Allway April 12th, 2021 Psychedelics, Top News VANCOUVER, BC, April 12, 2021 /PRNewswire/ – Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to provide the following shareholder update on its operations for the first quarter of 2021. The first quarter of 2021... Read more
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)
Ryan Allway April 12th, 2021 News, Top News Results expected to support the Company’s plans to file an IND application with the FDA for a Phase II international trial in acute myocarditis Oakville, Ontario–(Newsfile Corp. – April 12, 2021) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol” or the “Company”), a clinical-stage biotechnology... Read more
Psychedelics Wellness Company Delic: Proven Management Team with a Star-Studded Board
Ryan Allway April 9th, 2021 App, Exclusive, Psychedelics, Top News The psychedelics  sector is quickly evolving into a multi-billion-dollar industry with a growing number of publicly traded companies. As with any new industry, there are many companies backed by little more than financiers looking to make a quick dollar... Read more
Gage Cannabis Announces Exclusive Partnership With Blue River™ to Bring Award-Winning Cannabis Extracts to Michigan
Pursuant to the partnership and pending regulatory approval, Gage has been granted a license to produce and distribute Blue River™ branded products. Blue River™ products sold in Michigan will be manufactured with Gage’s premium flower. Subject to the receipt of applicable regulatory approvals, Blue River™’s brands are expected to be available... Read more
Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology
Ryan Allway April 7th, 2021 Psychedelics, Top News Agreement to explore the use of Silo Pharma’s Novel Peptide Englewood Cliffs, NJ, April 07, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that... Read more

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )